相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms
Debra Van Egeren et al.
CELL STEM CELL (2021)
Exosomes and Extracellular Vesicles in Myeloid Neoplasia: The Multiple and Complex Roles Played by These Magic Bullets
Simona Bernardi et al.
BIOLOGY-BASEL (2021)
Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design
Almudena Aguilera-Diaz et al.
PLOS ONE (2020)
Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm
Melissa Castiglione et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Extracellular Vesicles: From Biomarkers to Therapeutic Tools
Simona Bernardi et al.
BIOLOGY-BASEL (2020)
Driver Mutation Acquisition in Utero and Childhood Followed By Lifelong Clonal Evolution Underlie Myeloproliferative Neoplasms
Nicholas Williams et al.
BLOOD (2020)
ETV6: A Candidate Gene for Predisposition to Blend Pedigrees? A Case Report from the NEXT-Famly Clinical Trial
Simona Bernardi et al.
CASE REPORTS IN HEMATOLOGY (2020)
Absence of JAK2V617F Mutated Endothelial Colony-Forming Cells in Patients With JAK2V617F Myeloproliferative Neoplasms and Splanchnic Vein Thrombosis
Alexandre Guy et al.
HEMASPHERE (2020)
Vascular endothelial cell expression of JAK2(V617F) is sufficient to promote a pro-thrombotic state due to increased P-selectin expression
Alexandre Guy et al.
HAEMATOLOGICA (2019)
A systematic review and meta-analysis of the prevalence of thrombosis and bleeding at diagnosis of Philadelphia-negative myeloproliferative neoplasms
Tarinee Rungjirajittranon et al.
BMC CANCER (2019)
Cell Cytometry: Review and Perspective on Biotechnological Advances
Abhishek Vembadi et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2019)
New insights into the causes of thrombotic events in patients with myeloproliferative neoplasms raise the possibility of novel therapeutic approaches
Michal Bar-Natan et al.
HAEMATOLOGICA (2019)
Circulating endothelial cells as biomarker for cardiovascular diseases
Maura Farinacci et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2019)
Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm
Ricardo Helman et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
The JAK2V617F-bearing vascular niche promotes clonal expansion in myeloproliferative neoplasms
H. Zhan et al.
LEUKEMIA (2018)
Assessment of Endothelial Dysfunction With Flow-Mediated Dilatation in Myeloproliferative Disorders
Abdulkerim Yildiz et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2018)
Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features
Anna Guadall et al.
THROMBOSIS AND HAEMOSTASIS (2018)
DEPArray™ system: An automatic image-based sorter for isolation of pure circulating tumor cells
Mariano Di Trapani et al.
CYTOMETRY PART A (2018)
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients
Ayalew Tefferi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Development and clinical utility of a novel diagnostic nystagmus gene panel using targeted next-generation sequencing
Mervyn G. Thomas et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2017)
Isolation and genetic analysis of pure cells from forensic biological mixtures: The precision of a digital approach
F. Fontana et al.
FORENSIC SCIENCE INTERNATIONAL-GENETICS (2017)
Genetic Risk Assessment in Myeloproliferative Neoplasms
Ayalew Tefferi et al.
MAYO CLINIC PROCEEDINGS (2017)
Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation
C. Almici et al.
BONE MARROW TRANSPLANTATION (2017)
Myeloproliferative neoplasms: A decade of discoveries and treatment advances
Ayalew Tefferi
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Integrative analysis of copy number and gene expression data suggests novel pathogenetic mechanisms in primary myelofibrosis
Simona Salati et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Epidemiology and clinical relevance of mutations in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 359 patients of the AGIMM group
Giada Rotunno et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
How do I perform hematopoietic progenitor cell selection?
Scott T. Avecilla et al.
TRANSFUSION (2016)
Digital Sorting of Pure Cell Populations Enables Unambiguous Genetic Analysis of Heterogeneous Formalin-Fixed Paraffin-Embedded Tumors by Next Generation Sequencing
Chiara Bolognesi et al.
SCIENTIFIC REPORTS (2016)
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis
Elisa Rumi et al.
BLOOD (2014)
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms
Pontus Lundberg et al.
BLOOD (2014)
Molecular profiling of single circulating tumor cells with diagnostic intention
Bernhard Polzer et al.
EMBO MOLECULAR MEDICINE (2014)
Validation of a Next-Generation Sequencing Assay for Clinical Molecular Oncology
Catherine E. Cottrell et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2014)
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms
E. Tenedini et al.
LEUKEMIA (2014)
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients
P. Guglielmelli et al.
LEUKEMIA (2014)
JAK2V617F-positive endothelial cells contribute to clotting abnormalities in myeloproliferative neoplasms
S. Leah Etheridge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation
Vittorio Rosti et al.
BLOOD (2013)
Blood and endothelial cells: together through thick and thin
Luciana Teofili et al.
BLOOD (2013)
CANCER-ASSOCIATED THROMBOTIC DISEASE Myeloproliferative neoplasms and thrombosis
Tiziano Barbui et al.
BLOOD (2013)
Investigation of the freely available easy-to-use software 'EZR' for medical statistics
Y. Kanda
BONE MARROW TRANSPLANTATION (2013)
Mutations and prognosis in primary myelofibrosis
A. M. Vannucchi et al.
LEUKEMIA (2013)
Circulating Endothelial Cells in Patients with Venous Thromboembolism and Myeloproliferative Neoplasms
Claudia Torres et al.
PLOS ONE (2013)
wANNOVAR: annotating genetic variants for personal genomes via the web
Xiao Chang et al.
JOURNAL OF MEDICAL GENETICS (2012)
Endothelial progenitor cells are clonal and exhibit the JAK2V617F mutation in a subset of thrombotic patients with Ph-negative myeloproliferative neoplasms
Luciana Teofili et al.
BLOOD (2011)
Integrative genomics viewer
James T. Robinson et al.
NATURE BIOTECHNOLOGY (2011)
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
Francesco Passamonti et al.
BLOOD (2010)
Bone marrow is a reservoir for proangiogenic myelomonocytic cells but not endothelial cells in spontaneous tumors
Andrew C. Dudley et al.
BLOOD (2010)
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
A. Tefferi
LEUKEMIA (2010)
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Kai Wang et al.
NUCLEIC ACIDS RESEARCH (2010)
High Frequency of Endothelial Colony Forming Cells Marks a Non-Active Myeloproliferative Neoplasm with High Risk of Splanchnic Vein Thrombosis
Vittorio Rosti et al.
PLOS ONE (2010)
The presence of JAK2V617F mutation in the liver endothelial cells of patients with Budd-Chiari syndrome
Selcuk Sozer et al.
BLOOD (2009)
CD146-based immunomagnetic enrichment followed by multiparameter flow cytometry: a new approach to counting circulating endothelial cells
A. Widemann et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2008)
Bone marrow microvessel density in chronic myeloproliferative disorders: a study of 115 patients with clinicopathological and molecular correlations
Emanuela Boveri et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals
Mervin C. Yoder et al.
BLOOD (2007)
Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas
Jason L. Rowand et al.
CYTOMETRY PART A (2007)
Clonal analysis of mouse development reveals a polyclonal origin for yolk sac blood islands
Hiroo Ueno et al.
DEVELOPMENTAL CELL (2006)
A common progenitor for haematopoietic and endothelial lineages in the zebrafish gastrula
Kevin M. Vogeli et al.
NATURE (2006)
Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression
C. J. M. Loomans et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
Global gene expression profiling of circulating endothelial cells in patients with metastatic carcinomas
DA Smirnov et al.
CANCER RESEARCH (2006)
JANUS under stress - Role of JAK/STAT signaling pathway in vascular diseases
K Grote et al.
VASCULAR PHARMACOLOGY (2005)
Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood
DA Ingram et al.
BLOOD (2004)
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
JM Hill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
